Related Experiment Video
Updated: Aug 5, 2026

Electrophoretic Analysis of Replication Through Structure-Prone DNA Repeats Within the SV40-Based Human Episome
Published on: September 13, 2024
Reconciling the effects of PMS2 in different repeat expansion disease models supports a common expansion mechanism
Carson J Miller1, Diego Antonio Jimenez1, Alexandra Walker1
1Section on Gene Structure and Disease, Laboratory of Cell and Molecular Biology, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD 20892, USA.
Abstract:
Expansion of a disease-specific tandem repeat is responsible for >45 repeat expansion diseases (REDs). The expansion mutation in each of these diseases has different pathological consequences, and most are currently incurable. If the underlying mechanism of mutation is shared, a strategy that slows repeat expansion in one RED may be applicable to multiple REDs. However, the fact that PMS2, a component of the MutLα mismatch repair complex, promotes expansion in some models and protects against it in others suggests that the expansion mechanisms may differ. We show here using mouse models of two REDs caused by different repeats that PMS2 has similar effects in both models, with the loss of PMS2 resulting in an increase in expansions in some tissues and a loss of expansion in others. This is consistent with a protective effect of PMS2 in the first case and a role in promoting expansion in the second. Furthermore, we show in mouse embryonic stem cells that lower levels of PMS2 promote expansion while higher levels protect against it, with the ability to promote expansion depending on the PMS2 nuclease domain. Our findings lend support to the hypothesis that REDs share a common expansion mechanism and provide insights into the processes involved.
Insights
The MutLα mismatch repair protein PMS2 impacts repeat expansion diseases (REDs) differently depending on its levels and the specific repeat. Understanding this mechanism could lead to treatments for multiple incurable REDs.
Area of Science:
- Genetics
- Molecular Biology
- Genomic Instability
Background:
- Over 45 repeat expansion diseases (REDs) are caused by expanded tandem repeats.
- Most REDs are incurable, highlighting the need for effective therapeutic strategies.
- The role of PMS2 in repeat expansion is contradictory across different models, suggesting complex mechanisms.
Purpose of the Study:
- To investigate the shared mechanisms underlying repeat expansion in REDs.
- To determine the role of PMS2 in repeat expansion across different RED models.
- To explore how PMS2 levels influence repeat expansion and its potential therapeutic implications.
Main Methods:
- Utilized mouse models for two distinct REDs.
- Analyzed the effects of PMS2 loss on repeat expansion in various tissues.
- Investigated PMS2's role in mouse embryonic stem cells, manipulating PMS2 levels.
- Assessed the dependence of expansion promotion on the PMS2 nuclease domain.
Main Results:
- PMS2 exhibited varied effects, increasing expansion in some tissues and decreasing it in others across two RED models.
- Lower PMS2 levels promoted repeat expansion, while higher levels conferred protection in mouse embryonic stem cells.
- The nuclease activity of PMS2 was crucial for its role in promoting expansion.
Conclusions:
- Findings support a common expansion mechanism across different REDs.
- PMS2 plays a dual role in repeat expansion, influenced by its concentration and nuclease activity.
- This research provides critical insights into RED pathogenesis and potential therapeutic targets.
Related Concept Videos
Conservative Site-specific Recombination and Phase Variation
The recognition sites for Cre recombinase called LoxP...
Mismatch Repair
The Mutator Protein Family Plays a Key Role in DNA Mismatch Repair
The human genome has more than 3 billion base pairs of DNA per cell. Prior to cell division, that vast amount of genetic...
Mismatch Repair
Exon Recombination
Exon shuffling follows “splice frame rules.” Each exon has three reading...
Viral Recombination
Gene Conversion